1. Home
  2. IMC vs TNDM Comparison

IMC vs TNDM Comparison

Compare IMC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IMC Rare Earths Ltd Ordinary Shares

IMC

IMC Rare Earths Ltd Ordinary Shares

N/A

Current Price

$7.27

Market Cap

1.1B

ML Signal

N/A

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

N/A

Current Price

$15.74

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMC
TNDM
Founded
2025
2006
Country
Brazil
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
IMC
TNDM
Price
$7.27
$15.74
Analyst Decision
Buy
Analyst Count
0
25
Target Price
N/A
★ $27.86
AVG Volume (30 Days)
91.3K
★ 2.1M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,014,736,000.00
Revenue This Year
N/A
$5.69
Revenue Next Year
N/A
$12.35
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.93
52 Week Low
$4.80
$12.26
52 Week High
$11.84
$29.65

Technical Indicators

Market Signals
Indicator
IMC
TNDM
Relative Strength Index (RSI) 48.58 35.65
Support Level $6.37 $14.54
Resistance Level $8.29 $16.50
Average True Range (ATR) 1.02 0.97
MACD 0.01 0.05
Stochastic Oscillator 14.90 27.81

Price Performance

Historical Comparison
IMC
TNDM

About IMC IMC Rare Earths Ltd Ordinary Shares

IMC Rare Earths Ltd is a mineral exploration and development company engaged in the exploration, evaluation and development of minerals and metals in Brazil. Its main REE project is the Itarantim Project located in the States of Bahia and Minas Gerais, Brazil.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Share on Social Networks: